South Dakota § 34-20B-17 Opiates included in Schedule II.

South Dakota Statutes

§ 34-20B-17 — Opiates included in Schedule II.

South Dakota·Title 34 PUBLIC HEALTH AND SAFETY·Ch. 34-20 DRUGS AND SUBSTANCES CONTROL

Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

(1)Alphaprodine;

(2)Anileridine;

(3)Bezitramide;

(4)Diphenoxylate;

(5)Fentanyl;

(6)Isomethadone;

(7)Levomethorphan;

(8)Levorphanol;

(9)Metazocine;

(10)Methadone;

(11)Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane;

(12)Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;

(13)Pethidine;

(14)Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine;

(15)Pethidine-intermediate, B, ethyl

Free access — add to your briefcase to read the full text and ask questions with AI

Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule II, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation: (1) Alphaprodine; (2) Anileridine; (3) Bezitramide; (4) Diphenoxylate; (5) Fentanyl; (6) Isomethadone; (7) Levomethorphan; (8) Levorphanol; (9) Metazocine; (10) Methadone; (11) Methadone-intermediate, 4-cyano-2-dimethylamine-1, 4-diphenyl butane; (12) Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid; (13) Pethidine; (14) Pethidine-intermediate, A, 4-cyano-1-methyl-4-phenylpiperidine; (15) Pethidine-intermediate, B, ethyl-4-phenylpiperidine-4-carboxylate; (16) Pethidine-intermediate, C, 1-methyl-4-phenylpiperidine-4-carboxylic acid; (17) Phenazocine; (18) Piminodine; (19) Racemethorphan; (20) Racemorphan; (21) Sufentanil; (22) Alfentanil; (23) Carfentanil; (24) Levo-alphacetylmethadol, also known as levo-alpha-acetylmethadyl acetate or LAAM; (25) Remifentanil; (26) Oxymorphone; (27) Oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol); (28) 4-anilino-N-phenethylpiperidine (ANPP); (29) Morphine, except when it meets subdivision 34-20B-23 (8); (30) Hydrocodone (Dihydrocodeinone); (31) Codeine, except when it meets subdivision 34-20B-23 (1), 34-20B-23 (2), or 34-20B-26 (1); (32) Dihydrocodeine, except when it meets subdivision 34-20B-23 (5) or 34-20B-26 (2); (33) Ethylmorphine, except when it meets subdivision 34-20B-23 (6) or 34-20B-26 (3); (34) Oxycodone; (35) Hydromorphone; (36) Thiafentanil; (37) Noroxymorphone; (38) N-phenyl-N-(piperidin-4-yl)propionamide (norfentanyl); and (39) Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate).

South Dakota § 34-20B-17 (Opiates included in Schedule II.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

SL 1970, ch 229, § 8 (b) (1); SDCL Supp, § 39-17-60; SL 1985, ch 278, § 52; SL 1987, ch 255, § 4; SL 1989, ch 293, § 3; SL 1994, ch 278, § 3; SL 2002, ch 167, § 1; SL 2007, ch 194, § 1, eff. Feb. 1, 2007; SL 2008, ch 170, § 2, eff. Feb. 13, 2008; SL 2011, ch 160, § 2, eff. Feb. 24, 2011; SL 2015, ch 180, § 3, eff. Feb. 18, 2015; SL 2017, ch 156, § 2, eff. Feb. 3, 2017; SL 2020, ch 144, § 2, eff. Mar. 9, 2020; SL 2021, ch 144, § 5, eff. Feb. 17, 2021.